CDTX
Cidara Therapeutics Inc
NASDAQ: CDTX · HEALTHCARE · BIOTECHNOLOGY
$221.38
+0.00% today
Updated 2026-01-07
Market cap
$6.96B
P/E ratio
—
P/S ratio
4,540.70x
EPS (TTM)
$-11.20
Dividend yield
—
52W range
$15 – $221
Volume
1.5M
Cidara Therapeutics Inc (CDTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-0.69%
ROA
-0.29%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-792000.00 | — | — | — |
| 2013 | — | $-1.34M | — | — | — |
| 2014 | $0.00 | $-11.89M | — | — | — |
| 2015 | $0.00 | $-32.19M | — | — | — |
| 2016 | $0.00 | $-48.16M | — | — | — |
| 2017 | $0.00 | $-55.73M | — | — | — |
| 2018 | $0.00 | $-59.02M | — | — | — |
| 2019 | $20.91M | $-41.09M | -121.86% | -199.49% | -196.47% |
| 2020 | $12.07M | $-72.11M | 100.00% | -595.42% | -597.59% |
| 2021 | $49.57M | $-43.91M | 100.00% | -85.24% | -88.58% |
| 2022 | $64.29M | $-29.80M | 100.00% | -46.23% | -46.35% |
| 2023 | $23.28M | $-22.93M | -57.90% | -116.22% | -98.49% |
| 2024 | $1.27M | $-169.83M | 100.00% | -13,811.92% | -13,319.76% |